FibroGen (Mexico) Technical Analysis
| FGEN Stock | MXN 140.41 21.59 13.33% |
As of the 3rd of February, FibroGen shows the Coefficient Of Variation of (594.27), standard deviation of 2.91, and Mean Deviation of 1.34. FibroGen technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
FibroGen Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as FibroGen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to FibroGenFibroGen |
FibroGen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to FibroGen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of FibroGen.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in FibroGen on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding FibroGen or generate 0.0% return on investment in FibroGen over 90 days. FibroGen is related to or competes with Micron Technology, Southern Copper, FIBRA Storage, Verizon Communications, Burlington Stores, and Trade Desk. FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet... More
FibroGen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure FibroGen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess FibroGen upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 20.43 | |||
| Value At Risk | (7.73) |
FibroGen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for FibroGen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as FibroGen's standard deviation. In reality, there are many statistical measures that can use FibroGen historical prices to predict the future FibroGen's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (2.13) |
FibroGen February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (2.12) | |||
| Mean Deviation | 1.34 | |||
| Coefficient Of Variation | (594.27) | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.48 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (2.13) | |||
| Maximum Drawdown | 20.43 | |||
| Value At Risk | (7.73) | |||
| Skewness | (2.61) | |||
| Kurtosis | 10.21 |
FibroGen Backtested Returns
FibroGen secures Sharpe Ratio (or Efficiency) of -0.17, which denotes the company had a -0.17 % return per unit of standard deviation over the last 3 months. FibroGen exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm FibroGen's Standard Deviation of 2.91, coefficient of variation of (594.27), and Mean Deviation of 1.34 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.24, which means not very significant fluctuations relative to the market. As returns on the market increase, FibroGen's returns are expected to increase less than the market. However, during the bear market, the loss of holding FibroGen is expected to be smaller as well. At this point, FibroGen has a negative expected return of -0.53%. Please make sure to confirm FibroGen's standard deviation, information ratio, and the relationship between the coefficient of variation and variance , to decide if FibroGen performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
FibroGen has virtually no predictability. Overlapping area represents the amount of predictability between FibroGen time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of FibroGen price movement. The serial correlation of 0.08 indicates that barely 8.0% of current FibroGen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 59.2 |
FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
FibroGen Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for FibroGen across different markets.
About FibroGen Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of FibroGen on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of FibroGen based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on FibroGen price pattern first instead of the macroeconomic environment surrounding FibroGen. By analyzing FibroGen's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of FibroGen's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to FibroGen specific price patterns or momentum indicators. Please read more on our technical analysis page.
FibroGen February 3, 2026 Technical Indicators
Most technical analysis of FibroGen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for FibroGen from various momentum indicators to cycle indicators. When you analyze FibroGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (2.12) | |||
| Mean Deviation | 1.34 | |||
| Coefficient Of Variation | (594.27) | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.48 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (2.13) | |||
| Maximum Drawdown | 20.43 | |||
| Value At Risk | (7.73) | |||
| Skewness | (2.61) | |||
| Kurtosis | 10.21 |
FibroGen February 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as FibroGen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.87 | ||
| Day Median Price | 140.41 | ||
| Day Typical Price | 140.41 | ||
| Price Action Indicator | (10.80) |
Additional Tools for FibroGen Stock Analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.